nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—malignant glioma	0.703	1	CbGaD
Niclosamide—CYP1A2—Carmustine—malignant glioma	0.108	1	CbGbCtD
Niclosamide—STAT3—endothelium—malignant glioma	0.00728	0.179	CbGeAlD
Niclosamide—STAT3—blood vessel—malignant glioma	0.00671	0.165	CbGeAlD
Niclosamide—STAT3—embryo—malignant glioma	0.004	0.0982	CbGeAlD
Niclosamide—STAT3—brainstem—malignant glioma	0.00367	0.09	CbGeAlD
Niclosamide—STAT3—retina—malignant glioma	0.00354	0.0868	CbGeAlD
Niclosamide—STAT3—telencephalon—malignant glioma	0.00326	0.0799	CbGeAlD
Niclosamide—STAT3—medulla oblongata—malignant glioma	0.00256	0.0628	CbGeAlD
Niclosamide—STAT3—midbrain—malignant glioma	0.00234	0.0574	CbGeAlD
Niclosamide—STAT3—spinal cord—malignant glioma	0.00228	0.056	CbGeAlD
Niclosamide—STAT3—central nervous system—malignant glioma	0.00185	0.0454	CbGeAlD
Niclosamide—STAT3—cerebellum—malignant glioma	0.00181	0.0444	CbGeAlD
Niclosamide—STAT3—brain—malignant glioma	0.00147	0.036	CbGeAlD
Niclosamide—Diflunisal—PTGS1—malignant glioma	0.000715	0.336	CrCbGaD
Niclosamide—Meclofenamic acid—PTGS1—malignant glioma	0.000637	0.3	CrCbGaD
Niclosamide—Diflunisal—PTGS2—malignant glioma	0.000409	0.192	CrCbGaD
Niclosamide—Meclofenamic acid—PTGS2—malignant glioma	0.000364	0.171	CrCbGaD
Niclosamide—STAT3—Developmental Biology—PTPN11—malignant glioma	4.94e-05	0.000336	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PPARG—malignant glioma	4.85e-05	0.00033	CbGpPWpGaD
Niclosamide—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	4.85e-05	0.00033	CbGpPWpGaD
Niclosamide—STAT3—Immune System—DUSP6—malignant glioma	4.84e-05	0.00033	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SUFU—malignant glioma	4.78e-05	0.000325	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—PIK3CA—malignant glioma	4.73e-05	0.000322	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HEY2—malignant glioma	4.72e-05	0.000321	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—PTGS1—malignant glioma	4.71e-05	0.00032	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—AKT1—malignant glioma	4.7e-05	0.00032	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FBXW7—malignant glioma	4.69e-05	0.000319	CbGpPWpGaD
Niclosamide—STAT3—Disease—H3F3A—malignant glioma	4.68e-05	0.000319	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—AKT1—malignant glioma	4.68e-05	0.000319	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	4.62e-05	0.000314	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GFAP—malignant glioma	4.61e-05	0.000314	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT2—malignant glioma	4.6e-05	0.000313	CbGpPWpGaD
Niclosamide—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	4.59e-05	0.000313	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	4.58e-05	0.000312	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SPHK1—malignant glioma	4.46e-05	0.000304	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP2—malignant glioma	4.45e-05	0.000303	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	4.43e-05	0.000301	CbGpPWpGaD
Niclosamide—STAT3—Disease—JAG1—malignant glioma	4.42e-05	0.000301	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HEY1—malignant glioma	4.37e-05	0.000298	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR4—malignant glioma	4.37e-05	0.000298	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—AKT1—malignant glioma	4.36e-05	0.000297	CbGpPWpGaD
Niclosamide—STAT3—Disease—FBXW7—malignant glioma	4.33e-05	0.000295	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTT1—malignant glioma	4.29e-05	0.000292	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—AKT1—malignant glioma	4.26e-05	0.00029	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HIST1H3B—malignant glioma	4.25e-05	0.000289	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—FGF2—malignant glioma	4.23e-05	0.000288	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—EGFR—malignant glioma	4.19e-05	0.000285	CbGpPWpGaD
Niclosamide—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	4.14e-05	0.000282	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	4.12e-05	0.00028	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	4.1e-05	0.000279	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNA2—malignant glioma	4.1e-05	0.000279	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—KRAS—malignant glioma	4.03e-05	0.000274	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—PTGS1—malignant glioma	4.02e-05	0.000274	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KRAS—malignant glioma	3.96e-05	0.000269	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—RAF1—malignant glioma	3.95e-05	0.000269	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—ERBB2—malignant glioma	3.9e-05	0.000266	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—JAG2—malignant glioma	3.88e-05	0.000264	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—AKT1—malignant glioma	3.86e-05	0.000263	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—malignant glioma	3.75e-05	0.000255	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—PIK3CA—malignant glioma	3.7e-05	0.000252	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PIK3CA—malignant glioma	3.64e-05	0.000248	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTK2—malignant glioma	3.57e-05	0.000243	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—RTEL1—malignant glioma	3.52e-05	0.00024	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	3.49e-05	0.000237	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—GSTP1—malignant glioma	3.48e-05	0.000237	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	3.43e-05	0.000234	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN2B—malignant glioma	3.39e-05	0.000231	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP9—malignant glioma	3.35e-05	0.000228	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PDGFRA—malignant glioma	3.34e-05	0.000227	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-B—malignant glioma	3.31e-05	0.000226	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—H3F3A—malignant glioma	3.28e-05	0.000223	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCR3—malignant glioma	3.25e-05	0.000221	CbGpPWpGaD
Niclosamide—STAT3—Disease—HES1—malignant glioma	3.23e-05	0.00022	CbGpPWpGaD
Niclosamide—STAT3—Disease—NCOR1—malignant glioma	3.22e-05	0.000219	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	3.21e-05	0.000218	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NTRK2—malignant glioma	3.16e-05	0.000215	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—YWHAE—malignant glioma	3.16e-05	0.000215	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FLT1—malignant glioma	3.15e-05	0.000214	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	3.14e-05	0.000214	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	3.14e-05	0.000214	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—DUSP6—malignant glioma	3.13e-05	0.000213	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—JAG1—malignant glioma	3.09e-05	0.000211	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOTCH3—malignant glioma	3.08e-05	0.00021	CbGpPWpGaD
Niclosamide—STAT3—Disease—PDGFRA—malignant glioma	3.08e-05	0.00021	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-A—malignant glioma	3.07e-05	0.000209	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FBXW7—malignant glioma	3.03e-05	0.000206	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—RTEL1—malignant glioma	3.01e-05	0.000205	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—malignant glioma	3.01e-05	0.000205	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PDGFB—malignant glioma	3e-05	0.000204	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	2.99e-05	0.000203	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	2.99e-05	0.000203	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGFR1—malignant glioma	2.98e-05	0.000203	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—GSTP1—malignant glioma	2.98e-05	0.000203	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—BDKRB2—malignant glioma	2.97e-05	0.000202	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—AKT1—malignant glioma	2.97e-05	0.000202	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	2.96e-05	0.000202	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	2.93e-05	0.0002	CbGpPWpGaD
Niclosamide—STAT3—Disease—TERT—malignant glioma	2.83e-05	0.000193	CbGpPWpGaD
Niclosamide—STAT3—Disease—HLA-A—malignant glioma	2.83e-05	0.000193	CbGpPWpGaD
Niclosamide—STAT3—Disease—PDGFB—malignant glioma	2.77e-05	0.000188	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOTCH2—malignant glioma	2.76e-05	0.000188	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGFR1—malignant glioma	2.75e-05	0.000187	CbGpPWpGaD
Niclosamide—STAT3—Disease—HIF1A—malignant glioma	2.71e-05	0.000184	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EGFR—malignant glioma	2.71e-05	0.000184	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KNG1—malignant glioma	2.7e-05	0.000184	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BAD—malignant glioma	2.67e-05	0.000182	CbGpPWpGaD
Niclosamide—STAT3—Disease—CAV1—malignant glioma	2.62e-05	0.000178	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD80—malignant glioma	2.59e-05	0.000176	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—malignant glioma	2.58e-05	0.000175	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NTRK1—malignant glioma	2.58e-05	0.000175	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EGF—malignant glioma	2.56e-05	0.000174	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—KRAS—malignant glioma	2.56e-05	0.000174	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTPN11—malignant glioma	2.54e-05	0.000173	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.52e-05	0.000171	CbGpPWpGaD
Niclosamide—STAT3—Disease—BAD—malignant glioma	2.47e-05	0.000168	CbGpPWpGaD
Niclosamide—STAT3—Disease—NOTCH1—malignant glioma	2.44e-05	0.000166	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.43e-05	0.000166	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP3—malignant glioma	2.39e-05	0.000163	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD80—malignant glioma	2.39e-05	0.000163	CbGpPWpGaD
Niclosamide—STAT3—Disease—APC—malignant glioma	2.39e-05	0.000163	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN2B—malignant glioma	2.37e-05	0.000162	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT2—malignant glioma	2.37e-05	0.000161	CbGpPWpGaD
Niclosamide—STAT3—Disease—EGF—malignant glioma	2.36e-05	0.000161	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTPN11—malignant glioma	2.35e-05	0.00016	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTK2—malignant glioma	2.31e-05	0.000157	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CD—malignant glioma	2.27e-05	0.000155	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HES1—malignant glioma	2.26e-05	0.000154	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NCOR1—malignant glioma	2.25e-05	0.000153	CbGpPWpGaD
Niclosamide—STAT3—Disease—BRAF—malignant glioma	2.24e-05	0.000153	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT2—malignant glioma	2.18e-05	0.000149	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGF2—malignant glioma	2.18e-05	0.000148	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PDGFRA—malignant glioma	2.16e-05	0.000147	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.15e-05	0.000146	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CD—malignant glioma	2.1e-05	0.000143	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SPP1—malignant glioma	2.09e-05	0.000143	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.08e-05	0.000142	CbGpPWpGaD
Niclosamide—STAT3—Immune System—BCL2—malignant glioma	2.07e-05	0.000141	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNG—malignant glioma	2.05e-05	0.000139	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MDM2—malignant glioma	2.04e-05	0.000139	CbGpPWpGaD
Niclosamide—STAT3—Immune System—RAF1—malignant glioma	2.03e-05	0.000138	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—COX8A—malignant glioma	2.02e-05	0.000138	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGF2—malignant glioma	2.01e-05	0.000137	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ERBB2—malignant glioma	2.01e-05	0.000137	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TERT—malignant glioma	1.98e-05	0.000135	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CB—malignant glioma	1.98e-05	0.000135	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PDGFB—malignant glioma	1.94e-05	0.000132	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGFR1—malignant glioma	1.93e-05	0.000131	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT1—malignant glioma	1.92e-05	0.000131	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HIF1A—malignant glioma	1.9e-05	0.000129	CbGpPWpGaD
Niclosamide—STAT3—Disease—MDM2—malignant glioma	1.88e-05	0.000128	CbGpPWpGaD
Niclosamide—STAT3—Disease—RAF1—malignant glioma	1.87e-05	0.000128	CbGpPWpGaD
Niclosamide—STAT3—Disease—ERBB2—malignant glioma	1.85e-05	0.000126	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CAV1—malignant glioma	1.84e-05	0.000125	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CB—malignant glioma	1.83e-05	0.000125	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL1B—malignant glioma	1.83e-05	0.000124	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2—malignant glioma	1.82e-05	0.000124	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KDR—malignant glioma	1.81e-05	0.000124	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTGS2—malignant glioma	1.81e-05	0.000123	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.81e-05	0.000123	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—F2—malignant glioma	1.75e-05	0.000119	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FN1—malignant glioma	1.75e-05	0.000119	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—COX8A—malignant glioma	1.73e-05	0.000118	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—BAD—malignant glioma	1.73e-05	0.000118	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ASMT—malignant glioma	1.72e-05	0.000117	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTEN—malignant glioma	1.71e-05	0.000117	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NOTCH1—malignant glioma	1.71e-05	0.000116	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.68e-05	0.000114	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CD80—malignant glioma	1.67e-05	0.000114	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APC—malignant glioma	1.67e-05	0.000114	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CG—malignant glioma	1.67e-05	0.000114	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EGF—malignant glioma	1.65e-05	0.000113	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTPN11—malignant glioma	1.64e-05	0.000112	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—BCAN—malignant glioma	1.62e-05	0.00011	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTEN—malignant glioma	1.58e-05	0.000108	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—BRAF—malignant glioma	1.57e-05	0.000107	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.54e-05	0.000105	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT2—malignant glioma	1.53e-05	0.000104	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CD—malignant glioma	1.47e-05	0.0001	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ASMT—malignant glioma	1.47e-05	0.0001	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.44e-05	9.77e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGF2—malignant glioma	1.41e-05	9.58e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EGFR—malignant glioma	1.39e-05	9.48e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—BCAN—malignant glioma	1.38e-05	9.4e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MDM2—malignant glioma	1.32e-05	8.96e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KRAS—malignant glioma	1.31e-05	8.95e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—MYC—malignant glioma	1.31e-05	8.94e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RAF1—malignant glioma	1.31e-05	8.93e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—IDH2—malignant glioma	1.3e-05	8.87e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ERBB2—malignant glioma	1.3e-05	8.84e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—EGFR—malignant glioma	1.28e-05	8.75e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CB—malignant glioma	1.28e-05	8.72e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL8—malignant glioma	1.23e-05	8.38e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.23e-05	8.36e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.22e-05	8.34e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—KRAS—malignant glioma	1.21e-05	8.26e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CA—malignant glioma	1.21e-05	8.22e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CASP3—malignant glioma	1.18e-05	8.02e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2—malignant glioma	1.18e-05	8.01e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—IDH1—malignant glioma	1.12e-05	7.63e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CA—malignant glioma	1.12e-05	7.59e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—malignant glioma	1.11e-05	7.58e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—IDH2—malignant glioma	1.11e-05	7.58e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTEN—malignant glioma	1.11e-05	7.54e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SPHK1—malignant glioma	1.08e-05	7.38e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.06e-05	7.23e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.05e-05	7.15e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.05e-05	7.13e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1e-05	6.82e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—malignant glioma	1e-05	6.81e-05	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT1—malignant glioma	9.87e-06	6.72e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—IDH1—malignant glioma	9.57e-06	6.52e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SPHK1—malignant glioma	9.26e-06	6.31e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MYC—malignant glioma	9.2e-06	6.26e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.12e-06	6.21e-05	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT1—malignant glioma	9.11e-06	6.2e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP2C18—malignant glioma	9.08e-06	6.18e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EGFR—malignant glioma	9e-06	6.13e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.8e-06	5.99e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTT1—malignant glioma	8.59e-06	5.85e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.56e-06	5.83e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KRAS—malignant glioma	8.5e-06	5.79e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTGS1—malignant glioma	8.05e-06	5.48e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.02e-06	5.46e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CA—malignant glioma	7.81e-06	5.32e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.8e-06	5.31e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—malignant glioma	7.56e-06	5.14e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.52e-06	5.12e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—BCHE—malignant glioma	7.48e-06	5.09e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SLC5A5—malignant glioma	7.39e-06	5.03e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTT1—malignant glioma	7.34e-06	5e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.99e-06	4.76e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.93e-06	4.72e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTGS1—malignant glioma	6.88e-06	4.68e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.85e-06	4.67e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—BCHE—malignant glioma	6.39e-06	4.35e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT1—malignant glioma	6.38e-06	4.34e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SLC5A5—malignant glioma	6.32e-06	4.3e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.04e-06	4.11e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.97e-06	4.07e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GSTP1—malignant glioma	5.95e-06	4.05e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.92e-06	4.03e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAT—malignant glioma	5.79e-06	3.94e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NCOR1—malignant glioma	5.47e-06	3.72e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.16e-06	3.51e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GSTP1—malignant glioma	5.09e-06	3.46e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAT—malignant glioma	4.95e-06	3.37e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NCOR1—malignant glioma	4.68e-06	3.18e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CAV1—malignant glioma	4.46e-06	3.04e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.26e-06	2.9e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.06e-06	2.77e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PPARG—malignant glioma	3.92e-06	2.67e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CAV1—malignant glioma	3.81e-06	2.59e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.64e-06	2.48e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.57e-06	2.43e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.47e-06	2.36e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PPARG—malignant glioma	3.35e-06	2.28e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.11e-06	2.12e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTGS2—malignant glioma	3.08e-06	2.1e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.05e-06	2.08e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTEN—malignant glioma	2.69e-06	1.83e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.66e-06	1.81e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTGS2—malignant glioma	2.64e-06	1.79e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTEN—malignant glioma	2.3e-06	1.56e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.9e-06	1.29e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.62e-06	1.1e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKT1—malignant glioma	1.55e-06	1.06e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKT1—malignant glioma	1.32e-06	9.02e-06	CbGpPWpGaD
